Cellular dormancy in minimal residual disease following targeted therapy

Overview of attention for article published in Breast Cancer Research, June 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (65th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

twitter: 9 X users

Citations

dimensions_citation: 16 Dimensions

Readers on

mendeley: 36 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 9 X posts from 9 X users, with an upper bound of 33,283 followers.

RT @SN_Oncology: Read 'Cellular dormancy in minimal residual disease following targeted therapy' from #BreastCancerResearch for free: https…

14 Jun 2021

Reply Repost Favourite

Read 'Cellular dormancy in minimal residual disease following targeted therapy' from #BreastCancerResearch for free: https://t.co/9AQAIXijZi #Quiescence #Geneexpression #Targetedtherapy https://t.co/AN7Y1mQFma

14 Jun 2021

Reply Repost Favourite

Happy to see some of my work from undergrad published, wherein we find that the cells that drive relapse are distinct from those that drive primary tumorigenesis following targeted therapy in breast cancer https://t.co/wN3P0pLQwO

12 Jun 2021

Reply Repost Favourite

RT @JAguirreGhiso: Always nice to see converging data strengthening our understanding of cancer dormancy. New work from the Chodosh lab sho…

09 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.